Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin-induced hyperkalemia.

T E Edes1

  • 1Department of Medicine, Harry S. Truman Memorial Veterans Hospital, Columbia, MO 65201.

Postgraduate Medicine
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Heparin sodium can cause hyperkalemia, a serious electrolyte imbalance, particularly in patients with kidney problems or diabetes. Stopping heparin therapy is essential for recovery, with potassium levels typically normalizing within five days.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycemic index and insulin response to a liquid nutritional formula compared with a standard meal.

Journal of the American College of Nutrition·1998
Same author

Predicting energy needs in ventilator-dependent critically ill patients: effect of adjusting weight for edema or adiposity.

The American journal of clinical nutrition·1997
Same author

Comparison of serum and plasma leukotriene B4 levels in normal and asthmatic subjects.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1995
Same author

Beta carotene and cancer: where are we now?

Journal of the American College of Nutrition·1995
Same author

A piece of my mind. Home visit.

JAMA·1994
Same author

Carcinogen-induced tissue vitamin A depletion. Potential protective advantages of beta-carotene.

Annals of the New York Academy of Sciences·1993
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Area of Science:

  • Pharmacology
  • Nephrology
  • Endocrinology

Background:

  • Heparin sodium is a widely used anticoagulant with significant clinical benefits.
  • A potential adverse effect of heparin therapy is the development of hyperkalemia.
  • This complication is more prevalent in patients with compromised renal function or diabetes mellitus.

Observation:

  • Heparin therapy is associated with the development of hyperkalemia (elevated potassium levels).
  • This complication is more prevalent in patients with compromised renal function or diabetes mellitus.

Findings:

  • Heparin-induced hyperkalemia results from the suppression of aldosterone secretion.
  • Discontinuation of heparin is necessary to reverse this effect.
  • Hyperkalemia typically resolves within approximately five days after stopping heparin.

Related Experiment Videos

Implications:

  • Physicians must consider heparin as a potential cause of hyperkalemia in at-risk patients.
  • Monitoring potassium levels in patients on heparin, especially those with renal insufficiency or diabetes, is recommended.
  • Prompt recognition and management, including heparin cessation, can prevent severe hyperkalemia and its complications.